Crossmark

Impact of intravenous ferric carboxymaltose on physical performance and patient-reported outcomes in elderly patients with non-dialysis CKD, mild anemia, and iron deficiency: A pilot study

Crossref DOI link: https://doi.org/10.1016/j.nefro.2025.501418

Published Print: 2026-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Puchades, Maria Jesús https://orcid.org/0000-0001-6927-071X
Casas, Juan

Nuñez, Julio

Gimenez-Civera, Elena

Gonzales, Boris

Montomoli, Marco

de la Espriella, Rafael

Gonzalez-Rico, Miguel

Torregrosa, Isidro

Peña, Carlos J.

Cases, Aleix

Gorriz, Jose Luis
Funding

Funding for this research was provided by:

Vifor Pharma
License Information

Text and Data Mining valid from 2026-02-01

Text and Data Mining valid from 2026-02-01

Version of Record valid from 2025-09-11
More Information

This article is maintained by: Elsevier

Article Title: Impact of intravenous ferric carboxymaltose on physical performance and patient-reported outcomes in elderly patients with non-dialysis CKD, mild anemia, and iron deficiency: A pilot study

Journal Title: Nefrología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefro.2025.501418

Content Type: article

Copyright: © 2025 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Nefrología.

Document is current

Any future updates will be listed below